After analyzing the data, researchers found that participants who underwent cataract surgery had nearly 30 percent lower risk of developing dementia compared with those who did not have the procedure. The study also found that the reduction of risk continued for at least a decade following surgery and was associated specifically with the lower risk of Alzheimer’s.
“This is really exciting because no other medical intervention has shown such a strong association with lessening dementia risk in older individuals,” Cecilia S. Lee, ophthalmologist and the study’s lead author, said in a statement.
Thyme and oregano possess an anti-cancer compound that suppresses tumor development, but adding more to your tomato sauce isn’t enough to gain significant benefit. The key to unlocking the power of these plants is in amplifying the amount of the compound created or synthesizing the compound for drug development.
Researchers at Purdue University achieved the first step toward using the compound in pharmaceuticals by mapping its biosynthetic pathway, a sort of molecular recipe of the ingredients and steps needed.
“These plants contain important compounds, but the amount is very low and extraction won’t be enough,” said Natalia Dudareva, a Distinguished Professor of Biochemistry in Purdue’s College of Agriculture, who co-led the project. “By understanding how these compounds are formed, we open a path to engineering plants with higher levels of them or to synthesizing the compounds in microorganisms for medical use.
Researchers at Cortical Labs, a biotechnology startup, have successfully taught human brain cells in a petri dish how to play the 2D table tennis simulation video game “Pong”.
The team managed to create mini-brains consisting of 800,000 to one million living human brain cells in a petri dish, reports New Scientist. Regarding the unlikely study, Brett Kagan, chief scientific officer at Cortical Labs and research lead of the project, says We think… See more.
Advancing Veterinary Care With Predictive Diagnostics, AI & One Health Principles — Dr. Jennifer Ogeer, DVM, Antech Diagnostics, Mars Petcare, Mars Inc.
Dr. Jennifer Ogeer, DVM, MSC, MBA is Vice President of Medical Science & Innovation at Antech Diagnostics (https://www.antechdiagnostics.com/), one of the world’s largest reference laboratory networks, and a unit of Mars Veterinary Health (https://www.marsveterinary.com/).
Dr. Ogeer is also Chair of the Board Of Directors of Veterinarians Without Borders (https://www.vetswithoutborders.ca/), an organization that works with governments, educational institutions, non-governmental organizations, local communities, farmers’ groups, and international agencies, to tackle root-cause issues affecting public health, animal health and ecosystem health in developing communities around the world.
Dr. Ogeer is also Vice-Chair of the Diversify Veterinary Medicine Coalition (https://diversifyvetmed.org/) which is working to bring greater diversity to the veterinary profession.
Dr. Ogeer is a graduate of the Ontario Veterinary College (OVC), University of Guelph, Canada. She completed an emergency medicine/critical care residency at Tufts University/Angell Memorial Animal Hospital in Boston and a Master of Science degree in Critical Care at the Ontario Veterinary College. She also has completed an Executive MBA at Western University (Canada).
Dr. Ogeer is a highly experienced residency-trained emergency and critical care veterinarian with a rich and diverse background in clinical practice, academic teaching/education, research and business management consulting.
As a former associate professor she has worked in specialty referral hospitals and several university teaching hospitals, including University of Guelph, University of Saskatchewan and Texas A&M University.
Dr. Ogeer is an active member of the veterinary community, and has published various articles in peer-reviewed journals and conducted research on hospital-acquired infections and developed protocols for infectious disease outbreak management and prevention.
Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated enough, while on the other is technology—a cold, artificial entity that exists to bring convenience, structure and mathematical certainty in human lives. The contrast works well in combination, though, with biotechnology being an indispensable part of both healthcare and medicine. In addition to those two, there are several other applications in which biotechnology plays a central role—deep-sea exploration, protein synthesis, food quality regulation and preventing environmental degradation. The increasing involvement of AI in biotechnology is one of the main reasons for its growing scope of applications.
So, how exactly does AI impact biotechnology? For starters, AI fits in neatly with the dichotomous nature of biotechnology. After all, the technology contains a duality of its own—machine-like efficiency combined with the quaintly animalistic unpredictability in the way it works. In general terms, businesses and experts involved in biotechnology use AI to improve the quality of research and for improving compliance with regulatory standards.
More specifically, AI improves data capturing, analysis and pattern recognition in the following biotechnology-based applications:
Now their company, Sanas, is testing out artificial intelligence-powered software that aims to eliminate miscommunication by changing people’s accents in real time. A call center worker in the Philippines, for example, could speak normally into the microphone and end up sounding more like someone from Kansas to a customer on the other end.
Call centers, the startup’s founders say, are only the beginning. The company’s website touts its plans as “Speech, Reimagined.”
Eventually, they hope the app they’re developingwill be used by a variety of industries and individuals. It could help doctors better understand patients, they say, or help grandchildren better understand their grandparents.
Yiran Sherry’s waters broke while the family was stuck in traffic. With contractions increasing rapidly and traffic barely moving, the couple realized they were not going to make it in time.
Keating Sherry placed the vehicle on autopilot after setting the navigation system to the hospital, 20 minutes away in the western suburb of Paoli.
He said he laid one hand gently on the car’s steering wheel as he attended to his wife.
